Acute Pericarditis and Cardiac Tamponade in a Patient with COVID-19: A Therapeutic Challenge
View Full Paper
Ask AI
Bookmark
Share
Key result
Emergent pericardiocentesis and colchicine monotherapy successfully treated acute viral pericarditis and cardiac tamponade in a patient with COVID-19 and recent NSTEMI.
Why the study?
To highlight treatment challenges of acute viral pericarditis and cardiac tamponade in COVID-19, given uncertainty regarding the safety of standard treatment, and discuss complications of delayed diagnosis.
Design
Case report
Authors
Discussion
Loading...
Member takes
Implication
Tamponade should be considered in decompensating COVID-19 patients; leaves open optimal therapy amid treatment safety uncertainties.
Study Design
Type
Case Report (n=1)
Multicenter
No
Structured PICO
P
Population
A 70-year-old female with COVID-19 and a recent NSTEMI who developed acute viral pericarditis complicated by large pericardial effusion and cardiac tamponade.
I
Intervention
Treatment approach for acute pericarditis (considering NSAID safety concerns)
O
Outcome
Successful treatment and management of complications
Large pericardial effusion and cardiac tamponade should be considered in COVID-19 patients who decompensate after intubation, requiring careful management of acute pericarditis.
Limitations
- Single case report
- Testing for SARS-CoV-2 on pericardial fluid was not available
Cite This Study
Asif et al. (2020) conducted a case report in COVID-19 with acute pericarditis and cardiac tamponade (n=1). Pericardiocentesis and colchicine was evaluated. Emergent pericardiocentesis and colchicine monotherapy successfully treated acute viral pericarditis and cardiac tamponade in a patient with COVID-19 and recent NSTEMI.
View Full Paper
Ask AI
Bookmark
Share